SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001362310-08-008534
Filing Date
2008-12-23
Accepted
2008-12-23 17:26:04
Documents
3
Period of Report
2008-12-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c78707e8vk.htm 8-K 14442
2 EXHIBIT 99.1 c78707exv99w1.htm EX-99.1 7870
3 GRAPHIC c78707p7870701.jpg GRAPHIC 12941
  Complete submission text file 0001362310-08-008534.txt   42033
Mailing Address 7600 WISCONSIN AVE. SUITE 750 BETHESDA MD 20814
Business Address 7600 WISCONSIN AVE. SUITE 750 BETHESDA MD 20814 4256083008
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-33393 | Film No.: 081268330
SIC: 2834 Pharmaceutical Preparations